Changes in Cardiomyocyte Cell Cycle and Hypertrophic Growth During Fetal to Adult in Mammals.
Sanford P. Bishop,Yang Zhou,Yuji Nakada,Jianyi Zhang
DOI: https://doi.org/10.1161/JAHA.120.017839
IF: 6.106
2021-01-07
Journal of the American Heart Association
Abstract:The failure of adult cardiomyocytes to reproduce themselves to repair an injury results in the development of severe cardiac disability leading to death in many cases. The quest for an understanding of the inability of cardiac myocytes to repair an injury has been ongoing for decades with the identification of various factors which have a temporary effect on cell‐cycle activity. Fetal cardiac myocytes are continuously replicating until the time that the developing fetus reaches a stage of maturity sufficient for postnatal life around the time of birth. Recent reports of the ability for early neonatal mice and pigs to completely repair after the severe injury has stimulated further study of the regulators of the cardiomyocyte cell cycle to promote replication for the remuscularization of injured heart. In all mammals just before or after birth, single‐nucleated hyperplastically growing cardiomyocytes, 1X2N, undergo ≥1 additional DNA replications not followed by cytokinesis, resulting in cells with ≥2 nuclei or as in primates, multiple DNA replications (polyploidy) of 1 nucleus, 2X2(+)N or 1X4(+)N. All further growth of the heart is attributable to hypertrophy of cardiomyocytes. Animal studies ranging from zebrafish with 100% 1X2N cells in the adult to some strains of mice with up to 98% 2X2N cells in the adult and other species with variable ratios of 1X2N and 2X2N cells are reviewed relative to the time of conversion. Various structural, physiologic, metabolic, genetic, hormonal, oxygenation, and other factors that play a key role in the inability of post‐neonatal and adult myocytes to undergo additional cytokinesis are also reviewed. Nonstandard Abbreviations and Acronyms CDK cyclin dependent kinase P1 postnatal day 1 Rb retinoblastoma protein Systolic heart failure, resulting from cardiomyocyte loss, is the leading cause of heart failure, 1 which costs the US government >$39 billion in healthcare expenses annually. 2 The molecular and cellular basis for the progressive severe left ventricular dysfunction is the result of the inability of damaged and apoptotic myocytes to be replaced. The core pathophysiology of heart failure is the inability of the mammalian cardiomyocyte to regenerate. Instead, lost myocytes are replaced by fibrous tissue, which results in progressive left ventricular remodeling, dilatation, contractile dysfunction, and congestive heart failure that is irreversible. In contrast to lower vertebrates, 3 , 4 , 5 , 6 , 7 cardiomyogenesis after injury in adult mammals is limited 8 , 9 , 10 , 11 , 12 and insufficient for restoring normal cardiac function. Studies in the late 1990s elegantly mapped the DNA synthesis and cell cycle dynamics of rodent hearts during late fetal development and the early postnatal period, 13 , 14 , 15 showing that DNA synthesis drops significantly around birth. Cardiomyocyte DNA synthesis in the early neonatal period was thoroughly reviewed by Rumyantsev in 1977 13 and by others more recently. 14 In rats and mice, there is a renewed increase in DNA synthesis from postnatal day 4 (P4) to P10 as cardiomyocytes become binucleated and then drops to low levels. 14 , 15 , 16 In swine, and possibly other large mammalian species, DNA synthesis continues for several weeks after birth along with the development of multiple nuclei. 17 In rodents, cardiomyocytes activate the DNA synthesis tempora -Abstract Truncated-
cardiac & cardiovascular systems